08/01/2005
Federal Register Notice: FDA is announcing the rates for prescription drug user fees for fiscal year (FY) 2006 adjusted for inflat...08/01/2005
Federal Register Notice: FDA is announcing the rates and payment procedures for fiscal year (FY) 2006 animal drug user fees. The r...08/01/2005
Federal Register Notice: FDA is making available the final decision setting forth the findings of fact and conclusions of law on t...08/01/2005
Federal Register Final rule: FDA is amending the animal drug regulations by removing the portions reflecting approval of a new ani...08/01/2005
Federal Register Final rule: FDA is amending the animal drug regulations to reflect a change of sponsor for a new animal drug appl...07/28/2005
Federal Register Notice: FDA is denying Thomas M. Rodgers, Jr.'s request for a hearing and is issuing an order under the Federal F...07/28/2005
Federal Register Notice: FDA has determined the regulatory review period for Johnson & Johnson’s Zubrin (tepoxalin) is 1,887 days ...07/25/2005
Federal Register Notice: FDA’s proposed collection of information, “Current Good Manufacturing Practice Regulations for Finished P...